ArticleVaccine2008

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Igor S Lukashevich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.